| 2026-08-17 | Press release | United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis |
| 2026-08-05 | Deck | United Therapeutics Corporation Second Quarter 2026 Corporate Update August 5, 2026 |
| 2026-08-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-05 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-05 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-23 | Press release | United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors |
| 2026-07-23 | 8-K | Form 8-K, Item 5.02 |
| 2026-07-22 | Press release | United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August |
| 2026-07-02 | Press release | United Therapeutics Corporation Acquires Thymmune Therapeutics |
| 2026-07-02 | Press release | Press release · Jul 2026 |
| 2026-06-29 | Press release | Press release · Jun 2026 |
| 2026-06-29 | 8-K | Form 8-K, Item 5.02 |
| 2026-05-27 | Press release | United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference |
| 2026-05-26 | Press release | United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference |
| 2026-05-18 | Press release | Press release · May 2026 |
| 2026-05-17 | Press release | United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and P |
| 2026-05-17 | Press release | Press release · May 2026 |
| 2026-05-15 | Press release | Press release · May 2026 |
| 2026-05-12 | Press release | United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference |
| 2026-05-11 | Press release | Press release · May 2026 |
| 2026-05-11 | Press release | United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference |
| 2026-05-06 | Press release | United Therapeutics Corporation Reports First Quarter 2026 Financial Results |
| 2026-05-06 | Deck | DOWNLOAD OUR CORPORATE PRESENTATION · Q1 2026 |
| 2026-05-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-06 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-05 | Press release | United Therapeutics Corporation Reports First Quarter 2026 Financial Results |
| 2026-04-29 | Proxy | Definitive proxy statement |
| 2026-04-22 | Press release | United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026 |
| 2026-04-22 | Press release | United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026 |
| 2026-04-22 | Press release | United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and X |
| 2026-04-20 | Press release | Press release · Apr 2026 |
| 2026-04-08 | Press release | Press release · Apr 2026 |
| 2026-03-30 | Press release | Press release · Mar 2026 |
| 2026-03-30 | 8-K | Form 8-K, Item 8.01 |
| 2026-03-11 | Press release | Press release · Mar 2026 |
| 2026-03-09 | 8-K | Form 8-K, Item 1.01 |
| 2026-03-03 | Press release | United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference |
| 2026-03-03 | Press release | United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference |
| 2026-03-02 | Press release | United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulm |
| 2026-03-02 | Press release | Press release · Mar 2026 |